The relationship between microRNA-126 and maintenance therapy with bevacizumab after chemotherapy plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer: Results of the phase III Nordic ACT trial NCT00598156 translational study

Torben Frøstrup Hansen; René dePont Christensen; Rikke Fredslund Andersen; Karen-Lise Garm Spindler; Flemming Brandt Sørensen; Anders Johnsson; Anders Jakobsen

The relationship between microRNA-126 and maintenance therapy with bevacizumab after chemotherapy plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer: Results of the phase III Nordic ACT trial NCT00598156 translational study

Torben Frøstrup Hansen, René dePont Christensen, Rikke Fredslund Andersen, Karen-Lise Garm Spindler, Flemming Brandt Sørensen, Anders Johnsson, Anders Jakobsen

Publikation: Konferencebidrag uden forlag/tidsskrift › Poster › Forskning › peer review

Originalsprog	Engelsk
Publikationsdato	2012
Status	Udgivet - 2012
Begivenhed	ASCO 2012 - Chicago, USA Varighed: 1. jun. 2012 → 5. jun. 2012

Konference

Konference	ASCO 2012
Land	USA
By	Chicago
Periode	01/06/2012 → 05/06/2012

Citationsformater

Hansen, T. F., Christensen, R. D., Fredslund Andersen, R., Spindler, K-L. G., Sørensen, F. B., Johnsson, A., & Jakobsen, A. (2012). The relationship between microRNA-126 and maintenance therapy with bevacizumab after chemotherapy plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer: Results of the phase III Nordic ACT trial NCT00598156 translational study. Poster session præsenteret på ASCO 2012, Chicago, USA.

Hansen, Torben Frøstrup ; Christensen, René dePont ; Fredslund Andersen, Rikke ; Spindler, Karen-Lise Garm ; Sørensen, Flemming Brandt ; Johnsson, Anders ; Jakobsen, Anders. / The relationship between microRNA-126 and maintenance therapy with bevacizumab after chemotherapy plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer: Results of the phase III Nordic ACT trial NCT00598156 translational study. Poster session præsenteret på ASCO 2012, Chicago, USA.

@conference{9db24ab566b943989d20e4e5a3afb570,

title = "The relationship between microRNA-126 and maintenance therapy with bevacizumab after chemotherapy plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer: Results of the phase III Nordic ACT trial NCT00598156 translational study",

author = "Hansen, {Torben Fr{\o}strup} and Christensen, {Ren{\'e} dePont} and {Fredslund Andersen}, Rikke and Spindler, {Karen-Lise Garm} and S{\o}rensen, {Flemming Brandt} and Anders Johnsson and Anders Jakobsen",

year = "2012",

language = "English",

note = "null ; Conference date: 01-06-2012 Through 05-06-2012",

}

Hansen, TF , Christensen, RD , Fredslund Andersen, R, Spindler, K-LG, Sørensen, FB, Johnsson, A & Jakobsen, A 2012, 'The relationship between microRNA-126 and maintenance therapy with bevacizumab after chemotherapy plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer: Results of the phase III Nordic ACT trial NCT00598156 translational study', ASCO 2012, Chicago, USA, 01/06/2012 - 05/06/2012.

The relationship between microRNA-126 and maintenance therapy with bevacizumab after chemotherapy plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer: Results of the phase III Nordic ACT trial NCT00598156 translational study. / Hansen, Torben Frøstrup ; Christensen, René dePont ; Fredslund Andersen, Rikke; Spindler, Karen-Lise Garm; Sørensen, Flemming Brandt; Johnsson, Anders; Jakobsen, Anders.

2012. Poster session præsenteret på ASCO 2012, Chicago, USA.

Publikation: Konferencebidrag uden forlag/tidsskrift › Poster › Forskning › peer review

TY - CONF

T1 - The relationship between microRNA-126 and maintenance therapy with bevacizumab after chemotherapy plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer: Results of the phase III Nordic ACT trial NCT00598156 translational study

AU - Hansen, Torben Frøstrup

AU - Christensen, René dePont

AU - Fredslund Andersen, Rikke

AU - Spindler, Karen-Lise Garm

AU - Sørensen, Flemming Brandt

AU - Johnsson, Anders

AU - Jakobsen, Anders

PY - 2012

Y1 - 2012

M3 - Poster

Y2 - 1 June 2012 through 5 June 2012

ER -

Hansen TF , Christensen RD , Fredslund Andersen R, Spindler K-LG, Sørensen FB, Johnsson A et al. The relationship between microRNA-126 and maintenance therapy with bevacizumab after chemotherapy plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer: Results of the phase III Nordic ACT trial NCT00598156 translational study. 2012. Poster session præsenteret på ASCO 2012, Chicago, USA.